Affiliation:
1. Department of Neonatology, Shenzhen Baoan Women’s and Children’s Hospital, Shenzhen, 518100, China
2. Department of Obstetrics and Gynecology, Shenzhen Baoan Women’s and Children’s Hospital, Shenzhen, 518100, China
3. Department of Breast and Thyroid Surgery, Shenzhen Baoan Women’s and Children’s
Hospital, Shenzhen, 518100, China
Abstract
Abstract:
Inflammatory bowel disease (IBD), a chronic inflammatory condition of the
human intestine, comprises Crohn’s Disease (CD) and Ulcerative Colitis (UC). IBD
causes severe gastrointestinal symptoms and increases the risk of developing
colorectal carcinoma. Although the etiology of IBD remains ambiguous, complex
interactions between genetic predisposition, microbiota, epithelial barrier, and immune
factors have been implicated. The disruption of intestinal homeostasis is a cardinal
characteristic of IBD. Patients with IBD exhibit intestinal microbiota dysbiosis, impaired
epithelial tight junctions, and immune dysregulation; however, the relationship between
them is not completely understood. As the largest body surface is exposed to the
external environment, the gastrointestinal tract epithelium is continuously subjected to
environmental and endogenous stressors that can disrupt cellular homeostasis and
survival. Heat shock proteins (HSPs) are endogenous factors that play crucial roles in
various physiological processes, such as maintaining intestinal homeostasis and
influencing IBD progression. Specifically, HSPs share an intricate association with
microbes, intestinal epithelium, and the immune system. In this review, we aim to
elucidate the impact of HSPs on IBD development by examining their involvement in
the interactions between the intestinal microbiota, epithelial barrier, and immune
system. The recent clinical and animal models and cellular research delineating the
relationship between HSPs and IBD are summarized. Additionally, new perspectives
on IBD treatment approaches have been proposed.
Publisher
Bentham Science Publishers Ltd.